Managing safety reporting in the evolving regulatory environment of the Asia-Pacific region
51:38
Description
Related Videos
View More
View Less
Related Videos
In Latest Webinars
-
Play video Becoming a sponsor of choice for high-performing sites
Becoming a sponsor of choice for high-performing sites
59:59
-
Play video Webinar: When patients lead: Breaking barriers in ultra-rare disease drug development
Webinar: When patients lead: Breaking barriers in ultra-rare disease drug development
1:03:03
-
Play video Obesity studies: The enrolment vs. retention balancing act
Obesity studies: The enrolment vs. retention balancing act
Explore the future of obesity clinical trials with insights on market growth, patient retention strategies, and the latest drug development trends.
58:45
-
Play video ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
1:05:22
-
Play video Insights into first-in-human study design of oligonucleotides
Insights into first-in-human study design of oligonucleotides
58:57
-
Play video Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Learn how early COA strategy decisions can reduce clinical trial risks and strengthen evidence.
1:01:56
